Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.150
+0.010 (0.88%)
Nov 21, 2024, 11:46 AM EST - Market open
Oncternal Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 13.08 | 6.7 | 37.14 | 90.77 | 116.74 | 20.05 | Upgrade
|
| Short-Term Investments | 1.5 | 27.56 | 26.58 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 14.58 | 34.26 | 63.72 | 90.77 | 116.74 | 20.05 | Upgrade
|
| Cash Growth | -63.83% | -46.24% | -29.79% | -22.25% | 482.20% | -2.88% | Upgrade
|
| Accounts Receivable | 0.26 | 0.49 | 0.18 | 0.59 | - | - | Upgrade
|
| Other Receivables | 0.08 | 0.14 | - | 0.36 | - | - | Upgrade
|
| Receivables | 0.34 | 0.63 | 0.18 | 0.94 | - | - | Upgrade
|
| Prepaid Expenses | 0.53 | 1.17 | 3.39 | 1.14 | 1.27 | 0.74 | Upgrade
|
| Total Current Assets | 15.45 | 36.06 | 67.29 | 92.85 | 118 | 20.79 | Upgrade
|
| Property, Plant & Equipment | 0.15 | 0.26 | 0.09 | 0.08 | 0.04 | 0.19 | Upgrade
|
| Other Long-Term Assets | - | 0.41 | 1.27 | 0.66 | 0.77 | 0.77 | Upgrade
|
| Total Assets | 15.6 | 36.73 | 68.65 | 93.59 | 118.81 | 21.74 | Upgrade
|
| Accounts Payable | 1.2 | 1.15 | 2.92 | 1.96 | 1.14 | 0.87 | Upgrade
|
| Accrued Expenses | 5.06 | 3.88 | 4.68 | 3.43 | 3.03 | 2.71 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.17 | 0.09 | 0.08 | 0.04 | 0.1 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.63 | 3.64 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.01 | 0.02 | Upgrade
|
| Total Current Liabilities | 6.45 | 5.2 | 7.68 | 5.47 | 5.86 | 7.34 | Upgrade
|
| Long-Term Leases | - | 0.15 | - | - | - | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | 1.33 | - | - | - | - | Upgrade
|
| Total Liabilities | 6.45 | 6.68 | 7.68 | 5.47 | 5.86 | 7.43 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.05 | 0.05 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 232.33 | 227.83 | 219.26 | 202.2 | 195.7 | 79.87 | Upgrade
|
| Retained Earnings | -223.19 | -197.78 | -158.3 | -114.13 | -82.8 | -65.57 | Upgrade
|
| Comprehensive Income & Other | 0 | 0 | 0.01 | - | - | - | Upgrade
|
| Total Common Equity | 9.15 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
| Shareholders' Equity | 9.15 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
| Total Liabilities & Equity | 15.6 | 36.73 | 68.65 | 93.59 | 118.81 | 21.74 | Upgrade
|
| Total Debt | 0.19 | 0.32 | 0.09 | 0.08 | 0.04 | 0.19 | Upgrade
|
| Net Cash (Debt) | 14.39 | 33.94 | 63.64 | 90.69 | 116.7 | 19.86 | Upgrade
|
| Net Cash Growth | -64.00% | -46.67% | -29.83% | -22.29% | 487.57% | -3.80% | Upgrade
|
| Net Cash Per Share | 4.86 | 11.54 | 24.20 | 36.78 | 114.94 | 38.46 | Upgrade
|
| Filing Date Shares Outstanding | 2.96 | 2.96 | 2.94 | 2.47 | 2.46 | 0.77 | Upgrade
|
| Total Common Shares Outstanding | 2.96 | 2.95 | 2.87 | 2.47 | 2.44 | 0.77 | Upgrade
|
| Working Capital | 8.99 | 30.86 | 59.61 | 87.39 | 112.15 | 13.45 | Upgrade
|
| Book Value Per Share | 3.09 | 10.19 | 21.22 | 35.66 | 46.29 | 18.60 | Upgrade
|
| Tangible Book Value | 9.15 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
| Tangible Book Value Per Share | 3.09 | 10.19 | 21.22 | 35.66 | 46.29 | 18.60 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.